✦ LIBER ✦

567 POSTER Efficacy of BIBW 2992, an irreversible dual EGFR/HER2 receptor tyrosine kinase inhibitor, in combination with cytotoxic agents

✍ Scribed by F. Solca; A. Baum; F. Himmelsbach; A. Amelsberg; G. Adolf

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

573 POSTER Phase I study of BIBW2992, an

✍ R. Plummer; L. Vidal; L. Li; H. Shaw; R. Perrett; M. Shahidi; A. Amelsberg; G. T 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 67 KB

143 Growth response of human colorectal

✍ S. Khelwatty; S. Essapen; A.M. Seddon; H. Modjtahedi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB

9166 Activity of BIBW 2992, an irreversi

✍ De Greve, J.; Teugels, E.; Geers, C.; DeMey, J.; in 'tveld, P.; Decoster, L.; Ta 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 65 KB

A phase I dose escalation study of BIBW

✍ Eskens, F A L M; Mom, C H; Planting, A S T; Gietema, J A; Amelsberg, A; Huisman, 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 173 KB